v3 Template
A

Allogenica

Biotechnology / Healthcare ~240 employees
Founded
--
Employees (Est.)
~240
12 leaders known
Total Funding
$2.8M
Funding Rounds
1
Last Funding
2025-03-19

About Allogenica

Allogenica is a company focused on transforming cell therapies for a healthier tomorrow. Their mission is to disrupt the treatment landscape for cancer, rare diseases, and autoimmune disorders by developing a breakthrough cell therapy platform that aims to replace transplants, expand access to therapies, and dramatically reduce costs through streamlined production.

Products & Services

Allogeneic T-cell Therapies:A new generation of therapies using engineered pre-T cells derived from stem cells, designed to be safer, more accessible, and up to ten times less expensive to manufacture.
CAR-T Therapy Platform:A revolutionary application of their cell therapy platform aimed at reprogramming immune cells to target and kill cancer cells, with predictable safety and efficacy.

Specialties

Cell Therapy Allogeneic T-cell Therapies CAR-T Therapy Stem Cell Differentiation Bioproduction

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Grant
T: -
FT: Grant 		A: 2750000
MR: -
FA: €2.5 Million
FAN: 2750000 		D: 2025-03-19
FD: 2025-03-19 		1 investors
Grant Latest
2025-03-19
$2.8M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

I

Inna Menkova

CEO and Co-founder of Allogenica

LinkedIn (Pro only)
T

Tobias Abel

Chief Scientific Officer

LinkedIn (Pro only)
A

Aymeric Bordet

Chief Financial Officer

LinkedIn (Pro only)
J

Jean-Guillaume Lafay

Chairman of the Board of Directors and co-founder

J

Jean-Marie Grumel

Board member and co-founder

S

Stephane Legastelois, PhD

President at 33 Californie

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Allogenica Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~240 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro